Publications

Export 49 results:
Sort by: Author Title Type [ Year (Desc)]
2024
Ayoup, M. S., M. R. Barakat, H. Abdel-Hamid, E. Emam, Y. S. Al-Faiyz, A. A. Masoud, D. A. Ghareeb, A. Sonousi, and A. S. M. A. A. E. KASSAB, "Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents", RSC Medicinal Chemistry, 2024.
KASSAB, A. S. M. A. A. E., E. M. Gedawy, and A. S. Sayed, "Fused thiophene as a privileged scaffold: A review on anti-Alzheimer's disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and Aβ aggregation", International Journal of Biological Macromolecules, vol. 265, pp. 131018, 2024.
Farag, M. A., M. M. Kandeel, A. S. M. A. A. E. KASSAB, and S. I. Faggal, "Medicinal attributes of thienopyrimidine scaffolds incorporating the aryl urea motif as potential anticancer candidates via VEGFR inhibition", Archiv der Pharmazie, pp. e2400125, 2024.
KASSAB, A. S. M. A. A. E., "N-Acylhydrazone Pharmacophore's Analgesic and Anti-inflammatory Profile: Recent Advancements during the Past Ten Years", Current Pharmaceutical Design, vol. 30, pp. 333-351, 2024.
Sobh, E. A., A. S. M. A. A. E. KASSAB, E. A. El-Khouly, and M. S. A. Hassan, "New pyranopyrazole based derivatives: Design, synthesis, and biological evaluation as potential topoisomerase II inhibitors, apoptotic inducers, and antiproliferative agents", Bioorganic Chemistry, vol. 144, pp. 107158, 2024.
Ayoup, M. S., N. Khaled, H. Abdel-Hamid, D. A. Ghareeb, S. A. Nasr, A. Omer, A. Sonousi, A. S. M. A. A. E. KASSAB, and A. S. Eltaweil, "Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation", RSC Advances, vol. 14, pp. 7664–7675, 2024.
KASSAB, A. S. M. A. A. E., and E. M. Gedawy, "Recent Advancements in Refashioning of NSAIDs and their Derivatives as Anticancer Candidates", Current Pharmaceutical Design, vol. 30, pp. 1217-1239, 2024.
2023
KASSAB, A. S. M. A. A. E., "Anticancer agents incorporating the N‐acylhydrazone scaffold: Progress from 2017 to present", Archiv der Pharmazie, vol. 356, pp. e2200548, 2023.
KASSAB, A. S. M. A. A. E., "Benzotriazole scaffold: An overview of antiproliferative potential, mechanisms of action, and structure–activity relationships", Archiv der Pharmazie, vol. 356, pp. e2300102, 2023.
Swedan, H. K., A. S. M. A. A. E. KASSAB, E. M. Gedawy, and S. E. Elmeligie, "Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme", Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, issue 1, pp. 118–137, 2023.
Eissa, K. I., M. M. Kamel, L. W. Mohamed, A. S. Doghish, R. Alnajjar, A. A. Al‐Karmalawy, and A. S. M. A. A. E. KASSAB, "Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease", Drug Development Research, vol. 84, pp. 937–961, 2023.
Eissa, K. I., M. M. Kamel, L. W. Mohamed, and A. S. M. A. A. E. KASSAB, "Development of new Alzheimer's disease drug candidates using donepezil as a key model", Archiv der Pharmazie, vol. 356, pp. e2200398, 2023.
Shahin, I. G., K. O. Mohamed, A. T. Taher, M. M. Elsebaei, A. S. Mayhoub, A. S. M. A. A. E. KASSAB, and A. Elshewy, "New Phenylthiazoles: Design, Synthesis, and Biological Evaluation as Antibacterial, Antifungal, and Anti-COVID-19 Candidates", Chem. Biodiversity, vol. 20, pp. e202301143, 2023.
KASSAB, A. S. M. A. A. E., "Pyrazolo[3,4‐d]pyrimidine scaffold: A review on synthetic approaches and EGFR and VEGFR inhibitory activities", Archiv der Pharmazie, vol. 356, pp. e2200424, 2023.
Shahin, I. G., K. O. Mohamed, A. T. Taher, A. S. Mayhoub, and A. S. M. A. A. E. KASSAB, "Recent Advances in the Synthesis of Thiazole Ring: Mini Review", Mini-Reviews in Organic Chemistry, vol. 20, pp. 270-284, 2023.
Swedan, H. K., A. S. M. A. A. E. KASSAB, E. M. Gedawy, and S. E. Elmeligie, "Topoisomerase II inhibitors design: Early studies and new perspectives", Bioorganic Chemistry, vol. 136, pp. 106548, 2023.
2022
Shahin, I. G., K. O. Mohamed, A. T. Taher, A. S. Mayhoub, and A. S. M. A. A. E. KASSAB, "The Anti-MRSA Activity of Phenylthiazoles: A Comprehensive Review", Current Pharmaceutical Design, vol. 28, pp. 3469-3477, 2022.
Hassan, M. S. A., E. M. Ahmed, A. A. El‐Malah, and A. S. M. A. A. E. KASSAB, "Anti‐inflammatory activity of pyridazinones: A review", Arch. Pharm., vol. 355, pp. e2200067, 2022.
Abdelhaleem, E. F., A. S. M. A. A. E. KASSAB, H. B. El-Nassan, and O. M. Khalil, "Design and Synthesis of Novel Celecoxib Analogues with Potential Cytotoxic and Pro-apoptotic Activity against Breast Cancer Cell Line MCF-7", Medicinal Chemistry, vol. 18, pp. 903-914, 2022.
Abdelhaleem, E. F., A. S. M. A. A. E. KASSAB, H. B. El‐Nassan, and O. M. Khalil, "Design, synthesis, and biological evaluation of new celecoxib", ARCHIV DER PHARMAZIE, vol. 355, pp. e2200190, 2022.
Eissa, K. I., M. M. Kamel, L. W. Mohamed, M. A. Galal, and A. S. M. A. A. E. KASSAB, "Design, synthesis, and biological evaluation of thienopyrimidine and thienotriazine derivatives as multitarget anti‐Alzheimer agents", Drug Development Research, vol. 83, pp. 1394–1407, 2022.
Abdelhaleem, E. F., A. S. M. A. A. E. KASSAB, H. B. El‐Nassan, and O. M. Khalil, "Recent advances in the development of celecoxib analogs", Archiv der Pharmazie, vol. 355, pp. e2200326, 2022.
Maher, M., A. S. H. R. A. F. F. ZAHER, Z. Mahmoud, and A. S. M. A. A. E. KASSAB, "Recent green approaches for the synthesis of pyrazolo[3,4‐d]pyrimidines: A mini review", Arch. Pharm., vol. 355, pp. e2100470, 2022.
2021
KASSAB, A. S. M. A. A. E., E. M. Gedawy, M. I. A. Hamed, and A. S. D. & R. A. Hassan, "Design, synthesis, anticancer evaluation and molecular modeling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers", Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 36, issue 1, pp. 922-939, 2021.
2020
Gedawy, E. M., A. S. M. A. A. E. KASSAB, and A. E. M. Kerdawy, "Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors", European Journal of Medicinal Chemistry, vol. 189, pp. 112066, 2020.
Tourism